| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/31/2008 | WO2008090331A1 Serotonin reuptake inhibitors for treating arthritis |
| 07/31/2008 | WO2008090201A1 Use of folic acid, vitamin b6, and vitamin b12 |
| 07/31/2008 | WO2008089933A2 Benzoquinazole derivatives |
| 07/31/2008 | WO2008089669A1 A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 07/31/2008 | WO2008075978A3 An extract |
| 07/31/2008 | WO2008069688A3 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008063867A3 Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| 07/31/2008 | WO2008057580A3 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/31/2008 | WO2008008493A8 Alkyne-substituted pyridone compounds and methods of use |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182874 e.g. 1-[6-Chloro-5-[(tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]-2-quinolinyl]-4piperidinecarboxylic acid; adamantyl-containing purinergic receptor P2X7 antagonists; antiinflammatory agent, immune or cardiovascular diseases; asthma, chronic obstructive pulmonary disease, rheumatoid arthritis |
| 07/31/2008 | US20080182844 7-Substituted Aza-Indazoles, Compositions Containing Same, Production Method and Use Thereof |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182828 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen and a progestogen equivalent to 90 mu g per day of norgestimate; hot flushes |
| 07/31/2008 | US20080182822 Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182787 Protein isolated from plants (Moringa) or synthesized by recombinant DNA technology; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181917 Methods for therapeutic treatment of carpal tunnel syndrome |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/31/2008 | US20080181897 Which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation |
| 07/31/2008 | US20080181880 Inducing rapid bone formation; contains bone anabolic agent and a mechanical alteration device for altering contents of a bone marrow cavity, increase in osteoblast activity; antiresorptive agent for prevent resorption; drug targeting of specific bones |
| 07/31/2008 | US20080181879 Fibrin gel for controlled release of tgf-beta and uses thereof |
| 07/31/2008 | US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup |
| 07/31/2008 | DE102007003795A1 Verwendung von Folsäure, Vitamin B6 und Vitamin B12 Use of folic acid, vitamin B6 and vitamin B12 |
| 07/31/2008 | CA2674921A1 Benzoquinazoline derivatives |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1948798A1 Anti-alpha2 integrin antibodies and their uses |
| 07/30/2008 | EP1948692A2 Rankl antibody-pth/pthrp chimeric molecules |
| 07/30/2008 | EP1948689A1 High activity growth factor mutants |
| 07/30/2008 | EP1948245A2 Compositions and their uses for gene therapy of bone conditions |
| 07/30/2008 | EP1948194A2 Use of clodronic acid for the treatment of navicular syndrome |
| 07/30/2008 | EP1948185A2 Inhibitors of akt activity |
| 07/30/2008 | EP1846000A4 Pharmaceutical compositions containing bisphosphonate for improving oral absorption |
| 07/30/2008 | EP1656130B1 Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1159438B1 Use of adenoviral vector for synovial cell transduction |
| 07/30/2008 | EP1064009B2 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 07/30/2008 | EP0862616B1 Reconstituted mineralized cartilage tissue |
| 07/30/2008 | CN101233105A Tryptophan derivative and use thereof |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229370A Autologous T-cell vaccines against multiple sclerosis |
| 07/30/2008 | CN101229361A Healthy salt pillow |
| 07/30/2008 | CN101229356A External wad for treating cervical spondylosis |
| 07/30/2008 | CN101229355A Rheumatism soup |
| 07/30/2008 | CN101229353A Medicine compounds for treating rheumatoid and atrophic arthritis |
| 07/30/2008 | CN101229352A Total nutrition wine for treating rheumatic disease and preparing method thereof |
| 07/30/2008 | CN101229334A Medicine for treating rheumatoid and atrophic arthritis |
| 07/30/2008 | CN101229313A Hotspring powder medicine compounds |
| 07/30/2008 | CN101229311A Medicine for treating osteoporosis and preparing method thereof |
| 07/30/2008 | CN101229300A Chinese traditional medicine preparation for treating bone fracture |
| 07/30/2008 | CN101229299A Medicine promoting bone-knitting |
| 07/30/2008 | CN101229298A Externally used paste for treating wound, osteomyelitis and preparing method thereof |
| 07/30/2008 | CN101229295A Bone regeneration pain-relieving plaster |
| 07/30/2008 | CN101229281A Medicine for treating rheumatoid arthritis |
| 07/30/2008 | CN101229271A Rheumatism ostealgia medicated wine and preparing method thereof |
| 07/30/2008 | CN101229268A Retinervus-smoothing regeneration ointment |
| 07/30/2008 | CN101229261A Chinese traditional medicine compounds for treating eczema, measles, dermatitis and preparing method thereof |
| 07/30/2008 | CN101229255A Chinese traditional medicine formulation for treating acute waist injury |
| 07/30/2008 | CN101229244A Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof |
| 07/30/2008 | CN101229243A Ointment for bone fracture |
| 07/30/2008 | CN101229228A Medicine compounds for treating angiitis, phlebitis, osteomyelitis and preparing method thereof |
| 07/30/2008 | CN101229177A Medicine compounds for treating osteoporosis |
| 07/30/2008 | CN101229176A Capsule capable of increasing bone density and improving menopausal symptoms |
| 07/30/2008 | CN101229154A Medicine compounds for treating osteoporosis |
| 07/30/2008 | CN101229114A Free radical scavenging agent |
| 07/30/2008 | CN101228950A Deer bone, ginseng and antler soup and preparing method thereof |
| 07/30/2008 | CN101228915A Coral calcium tablet |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406053C First-aid medicine for treating acute medicochirurgic wound |
| 07/30/2008 | CN100406048C Quick fracture setting powder and its production process |
| 07/30/2008 | CN100406047C Chinese medicine for treating rheumatosis and rheumatoid disease |
| 07/30/2008 | CN100406044C Medicine for treating fracture and injury |
| 07/30/2008 | CN100406036C External-use Chinese medicine for treating arthritis and preparing method |
| 07/30/2008 | CN100406035C Chinese medicine preparation for treating protrasion of lumbar intervertebral disc |
| 07/30/2008 | CN100406016C Combinations of a cathepsin K inhibitor and a bisphophonate in the treatment of bone metastasis tumor, tumor growth and tumor-induced bone loss |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405213 such as 3-chloro-4-fluoro-N-(5-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}pyrimidin-2-yl)benzamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2461921C Composition of hypochlorous acid and its applications |
| 07/29/2008 | CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |